Catalysts About Sanofi India Sanofi India focuses on prescription pharmaceuticals, with a core emphasis on diabetes care and insulin therapies in the Indian market. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Sanofi India Sanofi India focuses on prescription medicines, with a core emphasis on diabetes and insulin therapies in the Indian market. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Sanofi India Sanofi India focuses on diabetes care, with a leading insulin portfolio and partnerships that extend its reach in cardiovascular and central nervous system therapies. What are the underlying business or industry changes driving this perspective?Read more
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.
